Government financing for embryonic stem cell research is allowed only for research using embryonic stem cell lines produced on or before Aug. 9, 2001, under a policy announced by President Bush on that time. Bush in July 2006 vetoed the Stem Cell Analysis Enhancement Act of 2005 , which would have extended stem cell lines that meet the criteria for federal government funding and allowed financing for analysis using stem cells produced from embryos originally designed for fertility treatments and willingly donated by individuals. Democratic congressional leaders this month intend to approve a bill similar to the Stem Cell Research Enhancement Work . According to the AP/Post, supporters of embryonic stem cell analysis say it could lead to treatments for conditions such as Parkinson’s disease and spinal cord injuries, while opponents of the extensive research state human embryos should not be destroyed for research purposes.Our leadership continues to set an important example through this annual initiative. We have witnessed pivotal modification as doctors, researchers, governmental bodies, educators and asbestos victims come to share information that has the energy to save lives together. We anticipate continued improvement and each full year we get nearer to a future without asbestos. .. Affymetrix reports first-quarter total revenue of $80.2M Affymetrix, Inc., today reported its operating results for the first one fourth of 2010. Total income for the quarter was $80.2 million, when compared with total revenue of $78.6 million in the first quarter of 2009.4 million, support revenue was $4.5 million, and royalties and other revenue were $2.3 million. This compares to first quarter 2009 product revenue of $64.9 million, services revenue of $11.6 million, and royalties and other revenue of $2.1 million.